It looks like you are using an older version of Internet Explorer which is not supported. We advise that you update your browser to the latest version of Microsoft Edge, or
consider using other browsers such as Chrome, Firefox or Safari.
ACC® helps to treat the congestion caused by too much sticky mucus or phlegm.1-5 Excess mucus or phlegm in your airways can be caused by a cold, flu, sinusitis or allergies.6
ACC® medications include the active ingredient acetylcysteine (uh-see-tuhl-si-steen).1-3,7 This ingredient works to break down thick or sticky mucus and phlegm in your airways.1-3 We call this type of medication a mucolytic.1-3
Medical studies show that mucolytic medication can reduce the intensity of a wet cough.5,8 Acetylcysteine, the active ingredient in ACC®, helps to reduce phlegmy coughing within four to five days of starting treatment.8
Acetylcysteine thins the phlegm produced by the lower airways and makes it more liquid so that it’s easier to cough up.8
Acetylcysteine’s thinning effect on thick or sticky mucus makes it easier to clear out your nasal passages and sinuses.5 This eases the discomfort and pressure that comes with sinus congestion.5
ACC® 600 effervescent tablets, ACC® Oral Solution and ACC® 200 are registered by the South African Health Products Regulatory Authority (SAHPRA) in South Africa. For more information, including safety precautions, read the ACC® product leaflets.
ACC® relieves mucus congestion in the airways1-3
HomeWhy ACC?How does ACC work?How to use ACC
[S1] ACC® 600 (effervescent tablets). Reg. No.: 45/10.3/0229. Composition: Each effervescent tablet contains 600 mg acetylcysteine. ATC Code: R05CB01.ACC® Oral Solution
[S1] ACC® 20 mg/ml Oral Solution. Reg. No.: 48/10.3/0261. Composition: Each 1 ml of ACC 20 mg/ml ORAL SOLUTION contains 20 mg acetylcysteine. ATC Code: R05CB01.ACC® 200
[S1] ACC® 200 (effervescent tablets). Reg. No.: 29/10.2.2/0753. Composition: Each ACC 200 effervescent tablet contains: 200 mg acetylcysteine. Pharmacological Classification: A10.3 Medicines acting on the respiratory system – other.
For full prescribing information refer to the Sandoz Professional Information approved by the South African Health Products Regulatory Authority (SAHPRA).
Sandoz SA (Pty) Ltd, Reg. No. 1990/001979/07,
Magwa Crescent West,
Tel: +27 (11) 347 6600.
SANCAL Customer Call Centre: 0861 726 225.
Reporting of AEs: https://www.report.novartis.com